Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTISON in Pediatric Echocardiography
NCT03740997Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- Dec 2020
- Primary completion
- Mar 2023
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of perflutren lipid microspheres in Structural Cardiac Abnormality, sponsored by GE HealthCare. Started Dec 2020; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
Structural Cardiac Abnormality
Beyond the preview
Go deeper on NCT03740997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740997.